Saratoga Health & Biotechnology I SBHIX
30.63 USD +0.14 (+0.46%)
At closeNov 4, 2026, 8:07 AM EST
Day range unavailable
24.95 52-week range 30.63
- YTD
- +18.49%
- 1 year
- +22.23%
- YTD return
- +18.49%
- 1-year return
- +22.23%
- Previous close
- 30.49
- 52-week range
- 24.95 – 30.63
2Y +5.87 (+23.84%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 24.38
- 200-day average
- 24.26
About Saratoga Health & Biotechnology I
The fund will normally invest at least 80% of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value (or "market capitalization"). Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SBHIX — it syncs with the Stock Master app.